-
-
-
-
-
-
-
Every Few Decades, Aesthetics Gets a New Category. One Preclinical Company Thinks Its Extra Cellular Matrix Platform Could Create the Next One
-
-
-
-
-
-
-
Abbvie (ABBV) PT Raised to $261 at Guggenheim
-
-
-
-
-
-
-
AbbVie shares gain on earnings beat, raised guidance
-
-
-
-
-
-
-
AbbVie beats Q4 expectations, shares dip
-
-
-
-
-
-
-
West Signs Agreement to Sell the Manufacturing and Supply Rights for SmartDoseĀ® 3.5mL On-Body Delivery System to AbbVie
-
-
-
-
-
-
-
AbbVie lifts full-year profit outlook amid strong psoriasis drug demand
-
-
-
-
-
-
-
AbbVie reports $2.7 billion IPR&D expense to impact Q3 earnings
-
1,224,169 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

